Pharma stays with health unit as MEPs OK new European Commission
This article was originally published in Scrip
Executive Summary
Strong pressure from health campaigners and some EU politicians appears to have paid off, as the incoming president of the European Commission, Jean-Claude Juncker, confirmed that responsibility for pharmaceuticals and medical devices would remain with the health directorate (DG SANCO) rather than being moved to the industry directorate as he had earlier proposed.
You may also be interested in...
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.
UK Explains New Rules On Parallel Imports From EU
Guidance from the Medicines and Healthcare products Regulatory Agency says that the packaging of parallel imported medicines must make clear that they are for the UK market only.